Skip to main content
Inify Laboratories AB logo

Inify Laboratories AB — Investor Relations & Filings

Ticker · INIFY ISIN · SE0017486103 LEI · 549300306YYJ3BX3VB98 ST Human health and social work activities
Open in API
Filings indexed 341 across all filing types
Latest filing 2024-05-15 AGM Information
Country SE Sweden
Listing ST INIFY

About Inify Laboratories AB

https://www.inify.com/

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. The company utilizes a fully digital, standardized, and AI-supported workflow for histopathology analysis. This integrated service model is designed to optimize the entire diagnostic process, from sample receipt to final report, ensuring high quality and significantly reduced turnaround times for clinical partners. Initially focused on prostate cancer, the company has expanded its diagnostic capabilities to include other areas such as gastroenterology. By streamlining the clinical pathway, Inify Laboratories enables healthcare providers to receive faster results, which facilitates earlier patient follow-up and treatment planning.

Recent filings

Filing Released Lang Actions
Inify Laboratories AB (publ) - kommuniké från årsstämma
AGM Information Classification · 99% confidence The document is titled "Inify Laboratories AB (publ) – kommuniké från årsstämma" which translates to 'communication from the Annual General Meeting (AGM)'. It details decisions made at the AGM held on May 14, 2024, including the approval of the 2023 financial statements, dividend disposition, granting of discharge to the board, decisions on remuneration, and re-election of board members and auditors. These are all core components of an AGM outcome summary. Since the document summarizes the results and decisions of the meeting rather than being a presentation (AGM-R) or a proxy solicitation document (DEF 14A/PSI), the most appropriate classification is AGM-R, which covers AGM materials/outcomes.
2024-05-15 Swedish
Inify Laboratories AB (publ) - summary of Annual General Meeting
AGM Information Classification · 99% confidence The document explicitly states it is a "summary of Annual General Meeting" held on May 14, 2024. It details resolutions passed regarding the adoption of accounts, disposition of financial results, discharge from liability, and remuneration for the Board of Directors and auditors. This content directly aligns with the purpose of an AGM summary or minutes, which falls under the 'AGM Information' category.
2024-05-15 English
Inify Laboratories AB (publ) - kommuniké från årsstämma
AGM Information Classification · 99% confidence The document title is "Inify Laboratories AB (publ) - kommuniké från årsstämma," which translates to "Inify Laboratories AB (publ) - communication from the Annual General Meeting (AGM)." The text details decisions made at the AGM held on May 14, 2024, including the approval of the 2023 financial statements, resolution on profit/loss disposition, granting of discharge to the board, decisions on remuneration, and re-election of board members and auditors. This content directly corresponds to the purpose of an AGM communication or minutes summary. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (3071 chars) is short, but it summarizes the meeting outcomes rather than just announcing the publication of a separate document, making AGM-R more specific than RPA or RNS.
2024-05-15 Swedish
Inify Laboratories AB (publ) - summary of Annual General Meeting
AGM Information Classification · 99% confidence The document explicitly states it is a "summary of Annual General Meeting" and details the resolutions passed during the meeting held on May 14, 2024, including the adoption of accounts, disposition of financial results, discharge from liability, and remuneration decisions. This content directly aligns with the definition of AGM Information.
2024-05-15 English
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 100% confidence The document is a 'Kvartalsrapport' (Quarterly Report) for Inify Laboratories AB for the first quarter of 2024. It contains detailed financial statements, key performance indicators (KPIs), management commentary, and operational updates. It is not a short announcement or a certification, but a comprehensive interim financial report. Q1 2024
2024-04-24 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report for the first quarter 2024' and contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business performance for the specified period. It is clearly a quarterly financial report, not an announcement of one, and contains substantive financial data. Q1 2024
2024-04-24 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.